Correlation Between Eterna Therapeutics and Xencor

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eterna Therapeutics and Xencor at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eterna Therapeutics and Xencor into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eterna Therapeutics and Xencor Inc, you can compare the effects of market volatilities on Eterna Therapeutics and Xencor and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eterna Therapeutics with a short position of Xencor. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eterna Therapeutics and Xencor.

Diversification Opportunities for Eterna Therapeutics and Xencor

-0.8
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Eterna and Xencor is -0.8. Overlapping area represents the amount of risk that can be diversified away by holding Eterna Therapeutics and Xencor Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xencor Inc and Eterna Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eterna Therapeutics are associated (or correlated) with Xencor. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xencor Inc has no effect on the direction of Eterna Therapeutics i.e., Eterna Therapeutics and Xencor go up and down completely randomly.

Pair Corralation between Eterna Therapeutics and Xencor

Given the investment horizon of 90 days Eterna Therapeutics is expected to under-perform the Xencor. In addition to that, Eterna Therapeutics is 1.95 times more volatile than Xencor Inc. It trades about -0.07 of its total potential returns per unit of risk. Xencor Inc is currently generating about 0.02 per unit of volatility. If you would invest  2,496  in Xencor Inc on September 12, 2024 and sell it today you would earn a total of  33.00  from holding Xencor Inc or generate 1.32% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Eterna Therapeutics  vs.  Xencor Inc

 Performance 
       Timeline  
Eterna Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eterna Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Xencor Inc 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Xencor Inc are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak fundamental indicators, Xencor reported solid returns over the last few months and may actually be approaching a breakup point.

Eterna Therapeutics and Xencor Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eterna Therapeutics and Xencor

The main advantage of trading using opposite Eterna Therapeutics and Xencor positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eterna Therapeutics position performs unexpectedly, Xencor can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xencor will offset losses from the drop in Xencor's long position.
The idea behind Eterna Therapeutics and Xencor Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Equity Valuation
Check real value of public entities based on technical and fundamental data
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios